Dr Leanne Alblas
2nd year Rheumatology trainee
Rheumatology for BPTs An introduction
Acknowledgment to Dr Claire Owen for many of the slides
Outline PMR and GCA
Monoarthritis
Polyarthritis
Back pain – Inflammatory vs. Mechanical
PMR and GCA
A 75-year-old woman is evaluated for a sudden loss of vision in the left eye that began 30
minutes ago. She has a 2-week history of fatigue; malaise; and pain in the shoulders, neck, hips,
and lower back. She also has a 5-day history of mild bitemporal headache.
On physical examination, temperature is 37.3 °C (99.1 °F), blood pressure is 140/85 mm Hg,
pulse rate is 72/min, and respiration rate is 16/min. BMI is 31. The left temporal artery is tender.
Fundoscopic examination reveals a pale, swollen optic disc. Range of motion of the shoulders
and hips elicits moderate pain.
Laboratory studies:
Hemoglobin 9.9 g/dL (99 g/L)
Leukocyte count 7300/µL (7.3 × 109/L)
Platelet count 456,000/µL (456 × 109/L)
Erythrocyte sedimentation rate 116 mm/h
Which of the following is the most appropriate next step in this patient’s management?
A) Brain MRI
B) High-dose intravenous methylprednisolone
C) Low-dose oral prednisolone
D) Temporal artery biopsy
Previous Exam Question GCA vs PMR
Previous Exam Question GCA Which of the following clinical features confers the highest likelihood for the presence of Giant Cell Arteritis?
A. Diplopia
B. Headache
C. Jaw Claudication
D. Large Joint Synovitis
E. Proximal Myalgia
Polymyalgia Rheumatica Polymyalgia Rheumatica (PMR) is a chronic,
inflammatory disorder of unknown cause
Characterised by sudden-onset shoulder and pelvic girdle pain, and prolonged early morning stiffness
Affects men and women over the age of 50 years
Most common inflammatory rheumatic disease of the elderly: Ranks second only to Rheumatoid Arthritis in terms of lifetime
incidence risk (2.43% for women and 1.66% for men)
Kermani, TA (2013). ‘Polymyalgia rheumatica’. Lancet; 381:63-72.
Crowson, CS et al. (2011). ‘The lifetime risk of ault-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases’. Arthritis &
Rheumatism;63(3):633-9.
Polymyalgia Rheumatica
Salvarani, C. et al. ‘Clinical features of polymyalgia rheumatica and giant cell arteritis’. Nature Reviews Rheumatology;8(9):509-21.
Figure 1: Typical sites of pain in patients with PMR. Shaded areas demonstrate the distribution in the a) shoulder and b) pelvic girdle.
Polymyalgia Rheumatica Heterogeneity in the clinical features and disease
course is well recognised:
Distal manifestations eg. Synovitis, tenosynovitis, pitting oedema, carpal tunnel syndrome (~50%)
GCA (16-21%): Up to 50% of GCA diagnoses have musculoskeletal symptoms
consistent with PMR
Polymyalgic-onset Rheumatoid Arthritis and spondyloarthritis
Dasgupta, B et al (2012). ‘Provisional classification criteria for polymyalgia rheumatica: a EULAR/ACR collaborative initiative’. Arthritis &
Rheumatism; 64(4):943-54.
Salvarini, C et al. ‘Polymyalgia rheumatica and giant cell arteritis’. Lancet; 372(9634):234-45.
Polymyalgia Rheumatica
Bilateral subacromial bursitis is the hallmark lesion of PMR on imaging:
Sensitivity 92.9%, specificity 99.1%
Ultrasound:
Preferred imaging technique
Findings of biceps tenosynovitis and trochanteric bursitis are similarly consistent with PMR
Camellino, D et al. (2012). ‘Imaging of polymyalgia rheumatica: indications on its pathogenesis, diagnosis and prognosis’. Rheumatology; 51(1):77-86.
Polymyalgia Rheumatica Diagnosis is based upon a clinical construct and raised
inflammatory markers:
Dasgupta, B et al (2012). ‘Provisional classification criteria for polymyalgia rheumatica: a EULAR/ACR collaborative initiative’. Arthritis &
Rheumatism; 64(4):943-54.
Polymyalgia Rheumatica Glucocorticoids remain the mainstay of treatment
The British Society for Rheumatology Guidelines for Management of PMR represent a recently developed consensus-based regimen:
PNL 15mg daily for 3 weeks
PNL 12.5mg daily for 3 weeks
PNL 10mg daily for 4 weeks, wean by 1mg every 4 weeks thereafter
The role of steroid-sparing agents is unclear
Dasgupta, B et al. (2010). BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology;49(1):186-90.
Kermani, TA (2013). ‘Polymyalgia rheumatica’. Lancet, 381:63-72.
Giant Cell Arteritis Also known as Temporal Arteritis
Giant Cell Arteritis (GCA) is a large-vessel vasculitis with a predilection for the aorta and its branches
The aetiology is unknown
Characterised by temporal headache (80%), scalp tenderness and jaw claudication
Most common vasculitis in men and women over 50 years of age
Salvarani, C. et al. ‘Clinical features of polymyalgia rheumatica and giant cell arteritis’. Nature Reviews Rheumatology;8(9):509-21.
GCA: history & examination features
1. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA 2002;287:92–101
Giant Cell Arteritis Ischaemic events are the most feared complication:
Anterior Ischaemic Optic Neuropathy (up to 20%)
Stroke (rare)
Long-term, GCA patients can develop large vessel aneurysms or stenosis
Salvarani, C. et al. ‘Clinical features of polymyalgia rheumatica and giant cell arteritis’. Nature Reviews Rheumatology;8(9):509-21.
Figure 3: Stenosis of the left subclavian artery on MRA in a GCA patient.
Giant Cell Arteritis Temporal artery biopsy is the diagnostic gold
standard:
Sensitivity ranges from ~70% to >90%
Breur, GS (2009). ‘Rate of discordant findings in bilateral temporal artery biopsy to diagnose giant cell arteritis’. Journal of Rheumatology; 36(4): 794.
Hunder, GG et al. (1990). ‘The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis’. Arthritis & Rheumatism;
33:1122-8.
Giant Cell Arteritis
American College of Rheumatology (2014). Available from: http://images.rheumatology.org
Figure 4: Temporal artery biopsy demonstrating segmental destruction of internal elastic lamina and granulomatous vessel inflammation with giant cells.
Giant Cell Arteritis The lack of a non-invasive diagnostic tool has
promoted the use of imaging modalities
Ultrasound:
Arterial wall oedema, seen as the halo sign, can be demonstrated in some patients with GCA: Sensitivity 42%, specificity 94%
Black, R et al (2013). ‘The use of temporal artery ultrasound in the diagnosis of giant cell arteritis in routine practice’. International Journal of
Rheumatic Diseases; 16:352-7.
Figure 5: Colour duplex ultrasound demonstrating the halo sign.
Giant Cell Arteritis Treatment should not be withheld prior to temporal
artery biopsy
Glucocorticoids similarly remain the mainstay of treatment:
Uncomplicated GCA (no visual loss) – PNL 50mg daily
Evolving visual loss – Methylprednisolone 1g IV for 3 consecutive days
Aspirin is also recommended in all patients with GCA without a major contraindication
Ghosh, P et al. (2010). ‘Current understanding and management of giant cell arteritis and polymyalgia rheumatica’. Expert Review Clinical
Immunology; 6(6): 913-28.
Giant Cell Arteritis A steroid-sparing agent should be considered
following recurrent relapse or failure to wean PNL
Ghosh, P et al. (2010). ‘Current understanding and management of giant cell arteritis and polymyalgia rheumatica’. Expert Review Clinical
Immunology; 6(6): 913-28.
Take Home Message
Condition Manifestations Investigations When to Refer
Giant Cell Arteritis • Temporal headache
• Scalp tenderness • Jaw claudication • Visual loss
• CRP – elevated • ESR – elevated • Temporal artery
biopsy
Immediately
Monoarthritis
Previous Exam Question Monoarthritis
A 78-year-old man with a 15-year history of osteoarthritis is evaluated for severe pain and swelling of the left knee of 4 days' duration. He also has hypertension, type 2 diabetes mellitus, and chronic kidney disease. Medications are glyburide, lisinopril, and low-dose aspirin. On physical examination, vital signs are normal. He is unable to bear weight on the left leg because of pain. The left knee is swollen and warm, and range of motion of this joint is limited and elicits pain. There are no tophi. Laboratory studies reveal leukocyte count 15,600/µL (15.6 × 109/L) (90% polymorphonuclear cells, 10% lymphocytes), glucose (random) 210 mg/dL (11.7 mmol/L), serum creatinine 2.2 mg/dL (167.9 µmol/L), serum uric acid 10.7 mg/dL (0.63 mmol/L) and normal urinalysis. Arthrocentesis of the left knee is performed. Synovial fluid leukocyte count is 24,000/µL (90% polymorphonuclear cells, 10% lymphocytes). Polarized light microscopy reveals intra- and extracellular monosodium urate crystals. Gram stain is negative. Q: Which of the following is the most appropriate treatment for this patient?
A. Allopurinol
B. Colchicine
C. Ibuprofen
D. Intra-articular methylprednisolone
E. Prednisone
Septic arthritis
Haemarthroses
Crystal arthritis: Gout
Pseudogout
“BBC”- Bugs, Blood, Crystals
DDx of acute monoarthritis
Acute Monoarthritis Can be the initial manifestation of many joint
disorders
Chokkalingam, S et al. (2003). ‘Diagnosing acute monoarthritis in adults: a practical approach for the family physician’. American Family Physician;
68(1):83-90.
Acute Monoarthritis Can be the initial manifestation of many joint
disorders
Chokkalingam, S et al. (2003). ‘Diagnosing acute monoarthritis in adults: a practical approach for the family physician’. American Family Physician;
68(1):83-90.
Acute Monoarthritis Arriving at the correct diagnosis is crucial for
appropriate treatment
Serious management errors can arise from:
Failing to perform a joint aspirate
Starting treatment before aspirating the joint
Basing a diagnosis purely on laboratory results eg. Serum urate level
Chokkalingam, S et al. (2003). ‘Diagnosing acute monoarthritis in adults: a practical approach for the family physician’. American Family Physician;
68(1):83-90.
Synovial Fluid Analysis
Lingling, M et al. (2009). ‘Acute monoarthritis: what is the cause of my patient’s painful swollen joint?’. CMAJ; 180(1):59-65.
Septic Arthritis Acute joint infection
Staphylococcus aureus is the most common organism
Risk factors include:
Age >80 years
Diabetes mellitus
Rheumatoid arthritis
Recent joint surgery
Hip or knee prosthesis
Skin infection
Lingling, M et al. (2009). ‘Acute monoarthritis: what is the cause of my patient’s painful swollen joint?’. CMAJ; 180(1):59-65.
Septic Arthritis Characterised by joint pain (85%), swelling (78%)
and limited range of motion
Fever may be absent (sensitivity 57%)
A synovial fluid leucocyte count >50000/mm3 is the most useful finding in making an early diagnosis:
Positive likelihood ratio 7.7 (CI 5.7 – 11.0)
Rapidly progressive joint destruction is seen on plain x-ray in untreated cases
Gout and sepsis may co-exist
Margaretten, ME et al. (2007). ‘Does this adult patient have septic arthritis?. JAMA; 297:1478-88.
Zhang, W et al (2006). ‘EULAR evidence based recommendations for gout: part 1: diagnosis.’ Annals of Rheumatic Disease; 65:1301-11.
Past Exam Question RA and septic arthritis Which of the following DMARDs is most likely to increase risk of septic arthritis in patients with Rheumatoid Arthritis?
A. Corticosteroids
B. Etanercept
C. Leflunomide
D. Methotrexate
E. Sulfasalazine
Infection Risk in Rheumatology Inflammatory conditions increase susceptibility to
infection due to: Underlying immune modulation of the disease process
Frequent use of glucocorticoids and immunosuppressive therapies
Prednisolone is associated with one of the highest overall infection risks
Most evidence suggests a neutral effect of synthetic DMARDs
Infection risk with TNF inhibitors is highest at commencement (RR 4.6 in first 90 days)
Gout Monosodium urate deposition in peri-articular soft
tissues
Risk factors include: Male sex
Diabetes mellitus
Hypertension
Obesity
Cardiovascular disease
Chronic renal failure
Diuretic use
Purine-rich diet
Alcohol consumption
Zhang, W et al (2006). ‘EULAR evidence based recommendations for gout: part 1: diagnosis.’ Annals of Rheumatic Disease; 65:1301-11.
Metabolic syndrome
Past Exam Question Purine metabolism QUESTION 16 What is the most common mechanism for primary hyperuricaemia? A. Increased gastrointestinal absorption of uric acid B. Increased cell turnover C. Inherited defects in purine synthesis D. Inherited defects in adenosine triphosphate (ATP) metabolism E. Reduced uric acid urinary excretion
Past Exam Question Purine metabolism QUESTION 16 What is the most common mechanism for primary hyperuricaemia? A. Increased gastrointestinal absorption of uric acid B. Increased cell turnover C. Inherited defects in purine synthesis D. Inherited defects in adenosine triphosphate (ATP) metabolism E. Reduced uric acid urinary excretion
Gout If polyarticular, typically asymmetrical in
distribution
Tophi have high clinical diagnostic value: Positive likelihood ratio 40.0 (95% CI 21.1-75.8)
The serum urate level neither confirms nor excludes the diagnosis
Needle-like, negatively birefringent crystals are seen on synovial fluid analysis
Zhang, W et al (2006). ‘EULAR evidence based recommendations for gout: part 1: diagnosis.’ Annals of Rheumatic Disease; 65:1301-11.
Figure 8: Tophi seen in the helices of the ear.
Gout Long-term, plain x-ray changes include juxta-
articular “punched-out” erosions
Zhang, W et al (2006). ‘EULAR evidence based recommendations for gout: part 1: diagnosis.’ Annals of Rheumatic Disease; 65:1301-11.
Figure 9: A gouty erosion seen along the medial margin of the first metatarsal head.
Past Exam Question Gout Treatment 62 yo man with hx of gout presents with acute painful arthritis of his 1st right MTP joint. He has mild renal impairment Cr. 136. What is the best treatment option?
A. NSAID's
B. Allopurinol
C. Colchicine
D. Probenecid
E. Corticosteroids
Gout Management of an acute attack: NEVER stop prophylaxis
Non-pharmacologic: ~15% decrease in serum urate level
Dietary modification (alcohol, purine-rich foods, fructose)
Weight loss and exercise (metabolic syndrome)
Pharmacologic:
Young and eGFR >50ml/min – NSAIDs
Elderly and eGFR >50ml/min – Colchicine 500mcg BD
Elderly and eGFR <50ml/min – Prednisolone Monoarticular (not MTP) – intra-articular corticosteroid
Polyarticular – PNL 25-30mg
Gout Prophylaxis: Indications:
Recurrent attacks
Tophi
Erosive change on plain x-ray
Nephrolithiasis
Commence 1-2 weeks after acute attack (consider ongoing medication)
Review every month and “treat to target” – serum urate level <0.36
Allopurinol
(Uricosuric agents eg. Probenicid)
Febuxostat (xanthine oxidase inhibitor)
Pseudogout Calcium pyrophosphate dihydrate crystal
deposition disease
Typically affects the knee and wrist joints
Risk factors include: OA
Hypercalcaemia
Hyperparathyroidism
Hypomagnesaemia
Hypothyroidism
Haemochromatosis
Lingling, M et al. (2009). ‘Acute monoarthritis: what is the cause of my patient’s painful swollen joint?’. CMAJ; 180(1):59-65.
Past Exam Question CPPD distribution QUESTION 37
Which of the these joints is most likely to be involved in pseudogout (calcium pyrophosphate deposition disease)?
A. Ankle
B. Knee
C. 1st Metacarpophalangeal
D. 1st Carpometacarpal
E. Wrist
Past Exam Question CPPD distribution QUESTION 37
Which of the these joints is most likely to be involved in pseudogout (calcium pyrophosphate deposition disease)?
A. Ankle
B. Knee
C. 1st Metacarpophalangeal
D. 1st Carpometacarpal
E. Wrist
Pseudogout Rhomboid, positively birefringent crystals are seen
on synovial fluid analysis
Chondrocalcinosis may be seen on plain x-ray:
Lingling, M et al. (2009). ‘Acute monoarthritis: what is the cause of my patient’s painful swollen joint?’. CMAJ; 180(1):59-65.
Figure 10: Calcification of the menisci and articular cartilage that is typical of chondrocalcinosis.
Pseudogout Management of an acute attack:
Young and eGFR >50ml/min – NSAIDs
Elderly and eGFR >50ml/min – Colchicine 500mcg BD
Elderly and eGFR <50ml/min – Prednisolone
Take Home Message
Condition Manifestations Investigations When to Refer
Acute Monoarthritis • Joint pain • Joint swelling • Limited range of
movement
• Joint aspirate • Blood cultures
Immediately
Polyarthritis
Rheumatoid Arthritis Chronic autoimmune disease that causes
inflammation and deformity of the joints
Prevalence 1%, twice as common in women as men
Precise aetiology remains unknown
Smoking is the best defined risk factor
Timely diagnosis is critical to prevent uncontrolled disease leading to irreversible joint damage
Ngian, G. (2010). ‘Rheumatoid arthritis’. Australian Family Physician; 39(9):626-628.
Rheumatoid Arthritis Typically, characterised by a symmetrical arthritis
affecting the wrists and, metacarpophalangeal and proximal interphalangeal joints of the hands
ESR and CRP are usually elevated at diagnosis and correlate with disease activity and treatment response
Testing for both rheumatoid factor and anti-CCP is
recommended
Ngian, G. (2010). ‘Rheumatoid arthritis’. Australian Family Physician; 39(9):626-628.
Rheumatoid Arthritis
Aletaha, D et al. (2010). ‘2010 Rheumatoid Arthritis Classification Criteria’. Arthritis & Rheumatism; 62(9):2569-81.
Rheumatoid Factor
• About 1% of the normal population has a detectable rheumatoid factor
In Rheumatoid Arthritis (RA), 70% of patients are rheumatoid factor positive:
Sensitivity 70%, specificity 85%
Its role in the pathogenesis of RA is unknown
Persistent high-titre rheumatoid factor predicts more severe disease
Karsten, K et al (2010). ‘Profiling of rheumatoid arthritis associated auto-antibodies’, Autoimmunity Reviews; 9:431-5.
Anti-Citrullinated Peptide Antibodies
Pathogenic auto-antibodies of RA
Similar sensitivity to rheumatoid factor, but superior specificity: Sensitivity 70%, specificity 95%
Detected in sera of patients years before symptom onset
Best prognostic indicator for erosive RA
Karsten, K et al (2010). ‘Profiling of rheumatoid arthritis associated auto-antibodies’, Autoimmunity Reviews; 9:431-5.
Anti-Nuclear Antibody
13-25% of the normal population have a
detectable ANA, 2.5% at high titre
Found in both systemic and organ-specific
autoimmune disease eg. Graves’ disease (50%)
Pattern correlates poorly with diagnoses, except
anti-centromere
If high titre, also check eNA and dsDNA
Satoh M. et al (2012). ‘Prevalence and sociodemographic correlates of antinuclear antibodies in the United States’. Arthritis and
Rheumatism;10:1002/art.34380.
Anti-Nuclear Antibody
Referrals to a tertiary centre Rheumatology Clinic for positive ANA: 232 patients
2.1% had Systemic Lupus Erythematosus, 9.1% had other ANA associated disease
No disease identified in patients with ANA <1:160
Abeles, A.M. & Abeles, M. (2013). ‘The clinical utility of a positive Antinuclear Antibody Test Result’. The American Journal of
Medicine’ : 126:342-8.
Rheumatoid Arthritis Rather than relying on surrogate markers of
inflammation, imaging is increasingly being utilised to assess disease activity
Plain x-ray: Historical gold standard of erosion assessment
Marginal erosions, peri-articular osteopaenia and joint space narrowing are classic features
X-Rays are abnormal at presentation in only 15-30% RA patients
Most useful for monitoring progression of joint damage over time
Yearly repetition is common practice
McQueen, F (2013). ‘Imaging in early rheumatoid arthritis’, Best Practice and Research Clinical Rheumatology; 27:499-522.
Rheumatoid Arthritis
American College of Rheumatology (2014). Available from: http://images.rheumatology.org
Figure 11: Typical plain x-ray changes in RA including marginal erosions, peri-articular osteopaenia and joint space narrowing.
Rheumatoid Arthritis Ultrasound:
Visualises both inflammatory disease activity and structural joint damage
Greyscale synovitis correlates highly with DAS28 and radiographic progression at 1 year
Detects 6.5-fold more erosions in early disease compared with plain x-ray
Power Doppler signal predicts clinical relapse (OR 6.3 95% CI 2.0-20.3)
Thiele, RG (2012). ‘Ultrasonography applications in diagnosis and management of early rheumatoid arthritis’, Rheumatic
Diseases Clinics of North America; 38:259-75.
Rheumatoid Arthritis
MRI: Ideally suited to image bony structures and cartilage,
as well as soft tissues and fluid
Detects erosions involving <20% bone volume loss of metacarpal head
Unique capacity to image bone marrow oedema
In undifferentiated arthritis, predicts RA onset with sensitivity of 100% and specificity of 78%
Availability, cost and contraindications problematic
McQueen, F (2013). ‘Imaging in early rheumatoid arthritis’, Best Practice and Research Clinical Rheumatology; 27:499-522.
Rheumatoid Arthritis
Aggressive treatment to achieve clinical remission is imperative: Symptomatic: Simple analgesia
NSAIDs/omega 3 fatty acids
Low-dose glucocorticoids eg. PNL 15mg daily
Disease modifying agents: Methotrexate
Combination DMARD therapy eg. MTX + HCQ + SSZ
Biologics eg. TNF inhibitors
Ngian, G. (2010). ‘Rheumatoid arthritis’. Australian Family Physician; 39(9):626-628.
Take Home Message
Condition Manifestations Investigations When to Refer
Inflammatory Polyarthritis
• Joint pain • Joint swelling • Extended early
morning stiffness
• ESR – elevated • CRP – elevated • Rheumatoid
factor • Anti-CCP • ANA
• Plain x-ray hands
Urgent outpatient referral
Back pain: Inflammatory vs. Mechanical
Past Exam Question An 18 year old has a two year history of recurrent swelling of the knees and ankles which usually settles after 1-2 weeks. They have also had intermittent crampy abdominal pain and diarrhoea for the last 6 months. The timing of the arthritis and diarrhoea do not appear to be related. Which test is most likely to make the diagnosis?
A. Colonoscopy
B. HLA-B27
C. Plain XR of the joints
D. Rheumatoid factor
E. Stool culture
Back pain features: Inflammatory vs. Mechanical
Golder, V & Schachna, L (2013). ‘Ankylosing spondylitis: an update’. Australian Family Physician; 42(11):780-4.
Spondyloarthritis Encompasses a group of rheumatic disorders that
share clinical, genetic and radiographic features
Golder, V & Schachna, L (2013). ‘Ankylosing spondylitis: an update’. Australian Family Physician; 42(11):780-4.
Ankylosing Spondylitis Chronic inflammatory condition of the sacroiliac
joints and spine
Affects 1 in 200 individuals
Male:female ratio 2:1
Extra-axial features include peripheral arthritis (up to 50%), enthesitis, dactylitis and anterior uveitis (40%)
Reduced spinal mobility is seen on examination
The delay between symptom onset and physician
Ankylosing Spondylitis
ESR and CRP are elevated in only 50-70% of cases
HLA-B27: Between 5-15% of the general population are HLA-
B27 positive, but only 5% of these develop AS
In AS patients, HLA-B27 occurs in 85-90%
Consequently, HLA-B27 has no role as a general screening test for spinal pain
Golder, V & Schachna, L (2013). ‘Ankylosing spondylitis: an update’. Australian Family Physician; 42(11):780-4.
Ankylosing Spondylitis Diagnosis requires inflammatory back pain and
changes on plain x-ray of the pelvis
Golder, V & Schachna, L (2013). ‘Ankylosing spondylitis: an update’. Australian Family Physician; 42(11):780-4.
Figure 13: Radiographic grading of sacroiliac joints.
Non-Radiographic Axial SpA Early presentation of AS,
prior to plain x-ray changes
50% of patients will evolve into AS
Golder, V & Schachna, L (2013). ‘Ankylosing spondylitis: an update’. Australian Family Physician; 42(11):780-4.
Ankylosing Spondylitis A tailored exercise and stretching program is
recommended
NSAIDs are first-line therapy for symptomatic AS
Traditional DMARDs play no role in axial disease
TNF inhibitors can be initiated in patients with an inadequate response to NSAIDs
Golder, V & Schachna, L (2013). ‘Ankylosing spondylitis: an update’. Australian Family Physician; 42(11):780-4.
Case 4 Management?
Tailored exercise and stretching program: www.nass.co.uk/exercise
Celecoxib 200mg daily
Semi-urgent outpatient Rheumatology referral Axial involvement non-responsive to above:
TNFi incl. Golimumab, Humira, Infliximab
Non-axial involvement
Methotrexate, Sulfasalazine
Past Exam Question A 23 yo male presents with 1 week of arthralgias and 2 days of arthritis of the left wrist and right knee. On examination there is tenosynovitis of the extensor tendons of the left forearm, and a pustular rash on the palm of his left hand. The most likely diagnosis is:
A. Ankylosing Spondylitis
B. Enteropathic arthritis
C. Gonococcal arthritis
D. Psoriatic arthritis
E. Reactive arthritis
Take Home Message
Condition Manifestations Investigations When to Refer
Inflammatory Low Back Pain
• Low back pain • Extended early
morning stiffness
• Peripheral arthritis
• Enthesitis • Dactylitis • Anterior uveitis*
• ESR – ?elevated • CRP – ?elevated
• Plain x-ray pelvis
• HLA-B27
Semi-urgent outpatient referral
Thank-you! Questions?